Recent Quotes
View Full List
My Watchlist
Create Watchlist
Indicators
DJI
Nasdaq Composite
SPX
Gold
Crude Oil
Markets
Stocks
Funds
Overview
Currencies
International
Treasuries
State Street SPDR S&P Biotech ETF
(NY:
XBI
)
127.37
-0.30 (-0.23%)
Official Closing Price
Updated: 8:00 PM EST, Feb 27, 2026
Add to My Watchlist
Quote
Overview
Detailed Quote
Charting
Historical Prices
News
All News
News Headlines
Press Releases
Research
Quarterly Reports
Insider Filings
Other Filings
Price and Volume
Detailed Quote
Volume
5,937,552
Open
126.07
Bid (Size)
126.10 (500)
Ask (Size)
127.30 (1,000)
Prev. Close
127.67
Today's Range
125.76 - 127.50
52wk Range
66.66 - 132.09
Shares Outstanding
541,500
Dividend Yield
1.28%
Intraday
1 Week
1 Month
3 Month
1 Year
3 Year
5 Year
Top News
More News
AKBA Shares Rise On Clinical Pipeline Optimism As Anemia Drug Gains Traction
↗
February 26, 2026
The company said on Thursday that it now expects its mid-stage trial of AKB-097 in rare kidney diseases to start in the second half of 2026, with initial data expected in 2027.
Via
Stocktwits
IBRX Stock Rises Pre-Market After ANKTIVA Combo Shows Stronger Bladder Cancer Responses In Phase 2 Trial
↗
February 26, 2026
The company said it plans to submit a biologics license application by the fourth quarter of 2026.
Via
Stocktwits
Performance
YTD
+4.8%
+4.8%
1 Month
+1.1%
+1.1%
3 Month
+3.4%
+3.4%
6 Month
+41.8%
+41.8%
1 Year
+46.2%
+46.2%
More News
Read More
CLDX Soars On Bullish Timelines For Urticaria Clinical Program: Retail Sees Experimental Skin Treatment’s Sales Beat Big Pharma’s Dupixent
↗
February 25, 2026
Via
Stocktwits
Topics
Earnings
RXRX Stock Soars Pre-Market On Q4 Beat, Recursion CEO Says Company Has ‘Reached An Inflection Point’
↗
February 25, 2026
Via
Stocktwits
Topics
Artificial Intelligence
Novavax Q4 Earnings Preview: Wall Street Expects Wider Losses Amid Diversification Efforts
↗
February 24, 2026
Via
Stocktwits
Topics
Artificial Intelligence
Earnings
Why Did PVLA Stock Surge 45% In Pre-Market Today?
↗
February 24, 2026
Via
Stocktwits
RARE Stock Edges Up On Priority Review For Gene Therapy In Rare Metabolic Disorder
↗
February 23, 2026
Via
Stocktwits
ImmunityBio Inks Partnerships To Launch Cancer Drug In Saudi Arabia Amid Expansion Efforts
↗
February 20, 2026
Via
Stocktwits
ARDX Stock Is Down Pre-Market After Q4 Earnings Miss, So Why Did This Firm Just Hike Price Target By 80%?
↗
February 20, 2026
Via
Stocktwits
Topics
Earnings
Intellectual Property
GRAL Stock Slumps After Hours As Trial For Cancer Test Fails To Show Reduction In Late-Stage Diagnoses
↗
February 19, 2026
Via
Stocktwits
Topics
Artificial Intelligence
Death
ARDX Stock Slips After Hours As Q4 Earnings Disappoint: Retail Sees Ibsrela Driving Outperformance In Time
↗
February 19, 2026
Via
Stocktwits
Topics
Artificial Intelligence
ImmunityBio Announces Partnership To Expand Access To Anktiva Across 30 Countries
↗
February 19, 2026
Via
Stocktwits
SNSE Stock Surges To 21-Month High – Everything To Know About Its Faeth Therapeutics Acquisition
↗
February 18, 2026
Via
Stocktwits
IBRX Gains 30% On Fresh Approval For Bladder Cancer Drug In EU: Retail, Wall Street Eyes Further Rally
↗
February 18, 2026
Via
Stocktwits
IBRX Stock Jumps 6% Pre-Market On BCG Update In Saudi Arabia – Retail Says Share Price Is ‘Attractive’
↗
February 17, 2026
Via
Stocktwits
IBRX Stokes Retail Chatter — Investors See Anktiva Beat Merck’s Keytruda With Approval In EU
↗
February 13, 2026
Via
Stocktwits
RARE Stock Slumps On Multiple Wall Street Price Target Slashes, Clinical Pipeline Uncertainty
↗
February 13, 2026
Via
Stocktwits
VKTX Stock Rallies After Hours On Optimism Around Company’s Obesity Pipeline
↗
February 11, 2026
Via
Stocktwits
Biotech Beat Nvidia in 2025. Can It Do It Again?
↗
February 11, 2026
Via
The Motley Fool
Topics
Artificial Intelligence
Sector Alert: 4 Healthcare ETFs Poised for Explosive Growth Now
↗
February 11, 2026
Via
The Motley Fool
Topics
Artificial Intelligence
ETFs
Economy
Why Did UPB Stock Pop 20% In Pre-Market Today?
↗
February 11, 2026
Via
Stocktwits
Why Did RGNX Shares Plummet 19% After-Hours Today?
↗
February 09, 2026
Via
Stocktwits
MDXG Stock Rises As MiMedx Enters Into Exclusive Distribution Agreement For Three Products
↗
February 04, 2026
Via
Stocktwits
Topics
Artificial Intelligence
RGNX Stock Is Falling Today — What Is The FDA Update On REGENXBIO's Gene Therapy?
↗
January 28, 2026
Via
Stocktwits
Why Did MNKD Stock Jump Over 7% In Pre-Market Today?
↗
January 26, 2026
Via
Stocktwits
Frequently Asked Questions
Is State Street SPDR S&P Biotech ETF publicly traded?
Yes, State Street SPDR S&P Biotech ETF is publicly traded.
What exchange does State Street SPDR S&P Biotech ETF trade on?
State Street SPDR S&P Biotech ETF trades on the New York Stock Exchange
What is the ticker symbol for State Street SPDR S&P Biotech ETF?
The ticker symbol for State Street SPDR S&P Biotech ETF is XBI on the New York Stock Exchange
What is the current price of State Street SPDR S&P Biotech ETF?
The current price of State Street SPDR S&P Biotech ETF is 127.37
When was State Street SPDR S&P Biotech ETF last traded?
The last trade of State Street SPDR S&P Biotech ETF was at 02/27/26 08:00 PM ET
What is the market capitalization of State Street SPDR S&P Biotech ETF?
The market capitalization of State Street SPDR S&P Biotech ETF is 68.97M
How many shares of State Street SPDR S&P Biotech ETF are outstanding?
State Street SPDR S&P Biotech ETF has 69M shares outstanding.
Stock Quote API & Stock News API supplied by
www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the
Privacy Policy
and
Terms Of Service
.
© 2025 FinancialContent. All rights reserved.